{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T15:25:53Z","timestamp":1792337153854,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34896-2","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T06:34:09Z","timestamp":1767594849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic effects and potential targets of UC-MSC-Exo in a mouse model of COPD"],"prefix":"10.1038","volume":"16","author":[{"given":"Yaping","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulipikaer","family":"Abudureheman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"10342","key":"34896_CR1","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/S0140-6736(22)00470-6","volume":"399","author":"SA Christenson","year":"2022","unstructured":"Christenson, S. A., Smith, B. M. & Bafadhel, M. Putcha, N. Chronic obstructive pulmonary disease. Lancet 399 (10342), 2227\u20132242 (2022).","journal-title":"Lancet"},{"issue":"5","key":"34896_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S2213-2600(21)00511-7","volume":"10","author":"D Adeloye","year":"2022","unstructured":"Adeloye, D. et al. Global, regional, and National prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: A systematic review and modelling analysis. Lancet Resp. Med. 10 (5), 447\u2013458 (2022).","journal-title":"Lancet Resp. Med."},{"issue":"12","key":"34896_CR3","doi-asserted-by":"publisher","first-page":"e2346598","DOI":"10.1001\/jamanetworkopen.2023.46598","volume":"6","author":"E Boers","year":"2023","unstructured":"Boers, E. et al. Global burden of chronic obstructive pulmonary disease through 2050. JAMA Netw. Open. 6 (12), e2346598 (2023).","journal-title":"JAMA Netw. Open."},{"issue":"1","key":"34896_CR4","doi-asserted-by":"publisher","first-page":"2531016","DOI":"10.1080\/15412555.2025.2531016","volume":"22","author":"J Liao","year":"2025","unstructured":"Liao, J. et al. Burden of chronic obstructive pulmonary disease in china: A global burden of disease study on Temporal Trends, risk factor Contributions, and projected disease burden from 1990 to 2030. COPD-J Chronic Obstr. Pulm Dis. 22 (1), 2531016 (2025).","journal-title":"COPD-J Chronic Obstr. Pulm Dis."},{"issue":"8","key":"34896_CR5","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jama.2019.0131","volume":"321","author":"CM Riley","year":"2019","unstructured":"Riley, C. M. & Sciurba, F. C. Diagnosis and outpatient management of chronic obstructive pulmonary disease: A review. JAMA 321 (8), 786\u2013797 (2019).","journal-title":"JAMA"},{"issue":"1","key":"34896_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s13287-024-04066-8","volume":"15","author":"T Jin","year":"2024","unstructured":"Jin, T., Liu, X., Li, G., Sun, S. & Xie, L. Intravenous injection of BMSCs modulate TsRNA expression and ameliorate lung remodeling in COPD mice. Stem Cell. Res. Ther. 15 (1), 450 (2024).","journal-title":"Stem Cell. Res. Ther."},{"key":"34896_CR7","doi-asserted-by":"publisher","first-page":"845042","DOI":"10.3389\/fbioe.2022.845042","volume":"10","author":"Y Ma","year":"2022","unstructured":"Ma, Y., Liu, X., Long, Y. & Chen, Y. Emerging therapeutic potential of mesenchymal stem Cell-Derived extracellular vesicles in chronic respiratory diseases: an overview of recent progress. Front. Bioeng. Biotechnol. 10, 845042 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"8","key":"34896_CR8","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.3390\/ijms26083785","volume":"26","author":"Y Chang","year":"2025","unstructured":"Chang, Y., Wu, K. & Ding, D. Enhancing the therapeutic potential of human umbilical cord mesenchymal stem cells for osteoarthritis: The role of Platelet-Rich plasma and extracellular vesicles. Int. J. Mol. Sci. 26(8), 3785 (2025).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"34896_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13287-025-04366-7","volume":"16","author":"C Wu","year":"2025","unstructured":"Wu, C. et al. Subchondral injection of human umbilical cord mesenchymal stem cells ameliorates knee osteoarthritis by inhibiting osteoblast apoptosis and TGF-beta activity. Stem Cell. Res. Ther. 16 (1), 235 (2025).","journal-title":"Stem Cell. Res. Ther."},{"issue":"11","key":"34896_CR10","doi-asserted-by":"publisher","first-page":"999","DOI":"10.4252\/wjsc.v15.i11.999","volume":"15","author":"H Li","year":"2023","unstructured":"Li, H., Ji, X., Zhang, S. & Bi, R. Hypoxia and inflammatory factor preconditioning enhances the immunosuppressive properties of human umbilical cord mesenchymal stem cells. World J. Stem Cells. 15 (11), 999\u20131016 (2023).","journal-title":"World J. Stem Cells"},{"issue":"1","key":"34896_CR11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s12890-025-03770-2","volume":"25","author":"Y Zhou","year":"2025","unstructured":"Zhou, Y., Zhou, W., Li, Y. & Zhang, J. MSCs regulate oxidative stress through the Nrf2 pathway to treat chronic obstructive pulmonary disease. BMC Pulm Med. 25 (1), 304 (2025).","journal-title":"BMC Pulm Med."},{"key":"34896_CR12","doi-asserted-by":"publisher","first-page":"117259","DOI":"10.1016\/j.biopha.2024.117259","volume":"178","author":"A Chakraborty","year":"2024","unstructured":"Chakraborty, A. et al. Induced pluripotent stem cell-derived mesenchymal stem cells reverse bleomycin-induced pulmonary fibrosis and related lung stiffness. Biomed. Pharmacother. 178, 117259 (2024).","journal-title":"Biomed. Pharmacother"},{"issue":"9","key":"34896_CR13","doi-asserted-by":"publisher","first-page":"8256","DOI":"10.3390\/ijms24098256","volume":"24","author":"YE Kim","year":"2023","unstructured":"Kim, Y. E. et al. SOCS3 protein mediates the therapeutic efficacy of mesenchymal stem cells against acute lung injury. Int. J. Mol. Sci. 24(9), 8256 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"34896_CR14","doi-asserted-by":"publisher","first-page":"1299384","DOI":"10.3389\/fonc.2023.1299384","volume":"13","author":"Y Song","year":"2023","unstructured":"Song, Y. et al. The potential applications of artificially modified exosomes derived from mesenchymal stem cells in tumor therapy. Front. Oncol. 13, 1299384 (2023).","journal-title":"Front. Oncol."},{"issue":"24","key":"34896_CR15","doi-asserted-by":"publisher","first-page":"13672","DOI":"10.3390\/ijms222413672","volume":"22","author":"G Kim","year":"2021","unstructured":"Kim, G. et al. Therapeutic potential of mesenchymal stem cells (MSCs) and MSC-Derived extracellular vesicles for the treatment of spinal cord injury. Int. J. Mol. Sci. 22(24), 13672 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"34896_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1186\/s13287-022-03122-5","volume":"13","author":"H Yari","year":"2022","unstructured":"Yari, H. et al. Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: A groundbreaking cell-free approach. Stem Cell. Res. Ther. 13 (1), 423 (2022).","journal-title":"Stem Cell. Res. Ther."},{"issue":"1","key":"34896_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13287-023-03287-7","volume":"14","author":"A Lotfy","year":"2023","unstructured":"Lotfy, A., AboQuella, N. M. & Wang, H. Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell. Res. Ther. 14 (1), 66 (2023).","journal-title":"Stem Cell. Res. Ther."},{"key":"34896_CR18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.reth.2022.07.002","volume":"21","author":"Q Chen","year":"2022","unstructured":"Chen, Q., Lin, J., Deng, Z. & Qian, W. Exosomes derived from human umbilical cord mesenchymal stem cells protect against papain-induced emphysema by preventing apoptosis through activating VEGF-VEGFR2-mediated AKT and MEK\/ERK pathways in rats. Regen Ther. 21, 216\u2013224 (2022).","journal-title":"Regen Ther."},{"issue":"1","key":"34896_CR19","first-page":"121","volume":"58","author":"H Guo-Parke","year":"2022","unstructured":"Guo-Parke, H., Linden, D., Weldon, S., Kidney, J. C. & Taggart, C. C. Deciphering Respiratory-Virus-Associated interferon signaling in COPD airway epithelium. Med. Lith. 58(1), 121 (2022).","journal-title":"Med. Lith."},{"key":"34896_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/ijpvm.ijpvm_297_23","volume":"15","author":"S Mathur","year":"2024","unstructured":"Mathur, S. & Singh, P. Chronic obstructive pulmonary disease: lifestyle impact. Int. J. Prev. Med. 15, 67 (2024).","journal-title":"Int. J. Prev. Med."},{"issue":"1","key":"34896_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4046\/trd.2024.0040","volume":"88","author":"JH Song","year":"2025","unstructured":"Song, J. H. & Kim, Y. Beyond the spirometry: new diagnostic modalities in chronic obstructive pulmonary disease. Tuberc Respir Dis. 88 (1), 1\u201313 (2025).","journal-title":"Tuberc Respir Dis."},{"issue":"3","key":"34896_CR22","doi-asserted-by":"publisher","first-page":"100253","DOI":"10.1016\/j.opresp.2023.100253","volume":"5","author":"J Tasch","year":"2023","unstructured":"Tasch, J. et al. Clinical manifestations of subjects with the Non-Specific pulmonary function test pattern. Open. Respir Arch. 5 (3), 100253 (2023).","journal-title":"Open. Respir Arch."},{"issue":"6","key":"34896_CR23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1164\/rccm.202005-1854OC","volume":"203","author":"BR Celli","year":"2021","unstructured":"Celli, B. R. et al. Pharmacotherapy and lung function decline in patients with chronic obstructive pulmonary disease. A systematic review. Am. J. Respir Crit. Care Med. 203 (6), 689\u2013698 (2021).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"6","key":"34896_CR24","doi-asserted-by":"publisher","first-page":"670","DOI":"10.4252\/wjsc.v16.i6.670","volume":"16","author":"Y Gao","year":"2024","unstructured":"Gao, Y. et al. Mesenchymal stem cells-extracellular vesicles alleviate pulmonary fibrosis by regulating immunomodulators. World J. Stem Cells. 16 (6), 670\u2013689 (2024).","journal-title":"World J. Stem Cells"},{"issue":"2","key":"34896_CR25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s12015-020-10085-8","volume":"17","author":"H Guo","year":"2021","unstructured":"Guo, H., Su, Y. & Deng, F. Effects of mesenchymal stromal Cell-Derived extracellular vesicles in lung diseases: current status and future perspectives. Stem Cell. Rev. Rep. 17(2), 440\u2013458 (2021).","journal-title":"Stem Cell. Rev. Rep."},{"key":"34896_CR26","doi-asserted-by":"crossref","unstructured":"Lesage, F. & Thebaud, B. Mesenchymal stromal Cell-Derived extracellular vesicles for neonatal lung disease: Tiny particles, major promise, rigorous requirements for clinical translation. Cells 11(7), 1176 (2022).","DOI":"10.3390\/cells11071176"},{"issue":"Pt 1","key":"34896_CR27","doi-asserted-by":"publisher","first-page":"136232","DOI":"10.1016\/j.ijbiomac.2024.136232","volume":"281","author":"Y Du","year":"2024","unstructured":"Du, Y. et al. Selenoprotein o as a regulator of macrophage metabolism in selenium deficiency-induced lung inflammation. Int. J. Biol. Macromol. 281 (Pt 1), 136232 (2024).","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"34896_CR28","doi-asserted-by":"publisher","first-page":"2301544","DOI":"10.1183\/13993003.01544-2023","volume":"65","author":"MM Mia","year":"2025","unstructured":"Mia, M. M. et al. YAP\/TAZ are crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis after bleomycin-induced injury. Eur. Respir. J. 65(6), 2301544 (2025).","journal-title":"Eur. Respir. J."},{"key":"34896_CR29","doi-asserted-by":"publisher","first-page":"874459","DOI":"10.3389\/fimmu.2022.874459","volume":"13","author":"H Yin","year":"2022","unstructured":"Yin, H. et al. Acute silica exposure triggers pulmonary inflammation through macrophage pyroptosis: an experimental simulation. Front. Immunol. 13, 874459 (2022).","journal-title":"Front. Immunol."},{"issue":"2","key":"34896_CR30","doi-asserted-by":"publisher","first-page":"101551","DOI":"10.1016\/j.jbc.2021.101551","volume":"298","author":"J Luo","year":"2022","unstructured":"Luo, J., De Pascali, F., Richmond, G. W., Khojah, A. M. & Benovic, J. L. Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4. J. Biol. Chem. 298 (2), 101551 (2022).","journal-title":"J. Biol. Chem."},{"key":"34896_CR31","doi-asserted-by":"publisher","first-page":"1178172","DOI":"10.3389\/fimmu.2023.1178172","volume":"14","author":"N Bekaddour","year":"2023","unstructured":"Bekaddour, N. et al. Targeting the chemokine receptor CXCR4 with Histamine analog to reduce inflammation in juvenile arthritis. Front. Immunol. 14, 1178172 (2023).","journal-title":"Front. Immunol."},{"key":"34896_CR32","doi-asserted-by":"publisher","first-page":"217097","DOI":"10.1016\/j.canlet.2024.217097","volume":"598","author":"A Shah","year":"2024","unstructured":"Shah, A. et al. Secretory trefoil factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in pancreatic ductal adenocarcinoma. Cancer Lett. 598, 217097 (2024).","journal-title":"Cancer Lett."},{"key":"34896_CR33","doi-asserted-by":"publisher","first-page":"852713","DOI":"10.3389\/fimmu.2022.852713","volume":"13","author":"C Wang","year":"2022","unstructured":"Wang, C. et al. Oxygen desaturation is associated with fibrocyte activation via epidermal growth factor Receptor\/Hypoxia-Inducible factor-1alpha axis in chronic obstructive pulmonary disease. Front. Immunol. 13, 852713 (2022).","journal-title":"Front. Immunol."},{"issue":"6","key":"34896_CR34","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1080\/08923973.2023.2228479","volume":"45","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Astragaloside IV restores Th17\/Treg balance via inhibiting CXCR4 to improve chronic obstructive pulmonary disease. Immunopharmacol. Immunotoxicol. 45 (6), 682\u2013691 (2023).","journal-title":"Immunopharmacol. Immunotoxicol"},{"issue":"4","key":"34896_CR35","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1165\/rcmb.2024-0303OC","volume":"73","author":"I Dupin","year":"2025","unstructured":"Dupin, I. et al. CXCR4 blockade alleviates pulmonary and cardiac outcomes in early COPD. Am. J. Respir Cell. Mol. Biol. 73(4), 530\u2013544 (2025).","journal-title":"Am. J. Respir Cell. Mol. Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34896-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34896-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34896-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T09:01:31Z","timestamp":1770195691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34896-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34896"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34896-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Animal Experiment Center of Xinjiang Medical University (IACUC\u221220231010\u221206 and 2023.10.10 of approval).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Approval for animal experiments"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"4741"}}